Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

JD Chalmers, J van Ingen… - European …, 2021 - Eur Respiratory Soc
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections.

JD Chalmers, J van Ingen… - European …, 2021 - search.ebscohost.com
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

[PDF][PDF] Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

JD Chalmers, J Ingen, R Laan, JL Herrmann - 2021 - repository.ubn.ru.nl
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

[HTML][HTML] Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

JD Chalmers, J van Ingen… - European …, 2021 - Eur Respiratory Soc
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

JD Chalmers, J van Ingen… - European …, 2021 - discovery.dundee.ac.uk
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections.

JD Chalmers, J van Ingen, R van der Laan… - … Review: an Official …, 2021 - europepmc.org
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections.

JD Chalmers, J van Ingen, R van der Laan… - 2021 - cabidigitallibrary.org
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

JD Chalmers, J van Ingen… - … review: an official …, 2021 - pubmed.ncbi.nlm.nih.gov
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

[PDF][PDF] Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

JD Chalmers, J van Ingen, R van der Laan… - 2021 - researchgate.net
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

[HTML][HTML] Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

JD Chalmers, J van Ingen, R van der Laan… - European Respiratory …, 2021 - ncbi.nlm.nih.gov
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …